Pharmaceutical behemoth Eli Lilly will slash the cost of its popular insulin products, relieving some of the financial burden on millions of Americans with .The company said Tuesday that it will cut prices of its Humalog and Humulin injections, its two best-selling insulin products, by 70 percent in the fourth quarter.And starting May 1, the company will lower the list price of unbranded insulin from $82 per vial to $25 per vial, the lowest level for insulin that diabetics take at mealtimes and less than the price of a Humalog vial in 1999.
Load More
Load More